Publication | Open Access
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
45
Citations
32
References
2019
Year
<sup>18</sup>F-FDG-PET-based radiomics is a promising approach for preoperatively evaluating the MGMT promoter methylation status in glioma and predicting the prognosis of glioma patients noninvasively.
| Year | Citations | |
|---|---|---|
Page 1
Page 1